| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Unit of Ophthalmology, Department of Medicine, the 2Molecular Genetics and Oncology Group, Clinical Dental Sciences, the 3Department of Pathology, The University of Liverpool, Liverpool, United Kingdom; and 4The Roy Castle International Centre for Lung Cancer Research, Liverpool, United Kingdom.
PURPOSE. To correlate monosomy 3 in uveal melanoma with clinical and histologic prognostic variables and death caused by metastatic disease.
METHODS. Loss of heterozygosity (LOH) on chromosome 3 was investigated by PCR-based microsatellite analysis in 105 tumors and related to large basal tumor diameter (LBD), ciliary body (CB) involvement, tumor cell type, periodic acid-Schiff (PAS)-positive loops, and death related to metastatic disease. A model relating monosomy 3 to these was created with forward-stepwise logistic regression and used to derive a prognostic index.
RESULTS. Monosomy 3 occurred in 54 (51%) tumors and regional chromosome 3 LOH in another six (6%) tumors. Monosomy 3 was associated with epithelioid cells (
2 test, P < 0.001), PAS-positive loops (2, P = 0.001), LBD (Mann-Whitney test, P = 0.002), CB involvement (2 test, P = 0.008), and metastasis-related death (log rank analysis, P = 0.0003). The regression coefficients indicated that epithelioid histology was 15 times as influential with each millimeter of increase in LBD. A prognostic score was derived: one point for each LBD category (<7.4, 7.5–12.4, 12.5–17.4, and >17.4 mm) and three points for epithelioid histology. The prevalence of monosomy 3 increased with score, from 0% in 18 tumors scoring less than 4 to 95% in 21 tumors scoring 7.
CONCLUSIONS. Monosomy 3 correlates with survival but can be predicted only in patients with large epithelioid tumors. The absence of monosomy 3 is predictable only in patients who have small, spindle-cell tumors. In most patients, prediction of monosomy 3 according to tumor size and histology is unreliable.
This article has been cited by other articles:
|
|
 |
|
  B. Damato, J. Dopierala, A. Klaasen, M. van Dijk, J. Sibbring, and S. E. Coupland Multiplex Ligation-Dependent Probe Amplification of Uveal Melanoma: Correlation with Metastatic Death Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3048 - 3055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Damato and S. E. Coupland Translating Uveal Melanoma Cytogenetics Into Clinical Care Arch Ophthalmol, April 1, 2009; 127(4): 423 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Mensink, J. Vaarwater, E. Kilic, N. C. Naus, N. Mooy, G. Luyten, H. T. Bruggenwirth, D. Paridaens, and A. de Klein Chromosome 3 Intratumor Heterogeneity in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 500 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Maat, L. V. Ly, E. S. Jordanova, D. de Wolff-Rouendaal, N. E. Schalij-Delfos, and M. J. Jager Monosomy of Chromosome 3 and an Inflammatory Phenotype Occur Together in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 505 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Harbour Molecular Prognostic Testing in Uveal Melanoma: Has It Finally Come of Age? Arch Ophthalmol, August 1, 2007; 125(8): 1122 - 1123. [Full Text] [PDF]
|
|
|
|
|
|
B. Damato Legacy of the Collaborative Ocular Melanoma Study Arch Ophthalmol, July 1, 2007; 125(7): 966 - 968. [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Onken, L. A. Worley, E. Person, D. H. Char, A. M. Bowcock, and J. W. Harbour Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for Predicting Metastasis in Uveal Melanoma Clin. Cancer Res., May 15, 2007; 13(10): 2923 - 2927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Meir, M. Zeschnigk, L. Masshofer, J. Pe'er, and I. Chowers The Spatial Distribution of Monosomy 3 and Network Vasculogenic Mimicry Patterns in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1918 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sandinha, M. Farquharson, I. McKay, and F. Roberts Correlation of Heterogeneity for Chromosome 3 Copy Number with Cell Type in Choroidal Melanoma of Mixed-Cell Type Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5177 - 5180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Kadkol, A. Y. Lin, V. Barak, I. Kalickman, L. Leach, K. Valyi-Nagy, D. Majumdar, S. Setty, A. J. Maniotis, R. Folberg, et al. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 802 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Sandinha, M. A. Farquharson, I. C. McKay, and F. Roberts Monosomy 3 Predicts Death but Not Time until Death in Choroidal Melanoma Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3497 - 3501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M T Sandinha, M A Farquharson, and F Roberts Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation Br. J. Ophthalmol., December 1, 2004; 88(12): 1527 - 1532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cruz III, B. P. Rubin, D. Wilson, A. Town, A. Schroeder, A. Haley, T. Bainbridge, M. C. Heinrich, and C. L. Corless Absence of BRAF and NRAS Mutations in Uveal Melanoma Cancer Res., September 15, 2003; 63(18): 5761 - 5766. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
